INCY Incyte Corporation - Common Stock
$127,56
Harga · Agu 21, 2026
Fundamental per Jul 28, 2026
Rentang 52M
$81–$133
90% of range
Peringkat Analis
HOLD
33 analysts
Target Harga
$125
P/E (TTM)
19.9
ROE
27.6%
Margin Laba Bersih
25.0%
Tentang Incyte Corporation - Common Stock Tinjauan perusahaan dari Wikipedia
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
Baca selengkapnya
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity.
History
Incyte Corporation was founded by Roy A. Whitfield on April 8, 1991, in Palo Alto, California, as a genomics company. It became a public company in 1993. Subsequently, scientists and chemists were recruited from DuPont to work for Incyte. Incyte moved its headquarters to Delaware, and acquired Maxia Pharmaceuticals in 2003.
In November 2013, Incyte announced its relocation to new headquarters in Wilmington, Delaware, completing the move by the end of 2014. Hervé Hoppenot became CEO in January 2014.
In 2017, the company became part of the S&P 500 Index, which tracks the 500 most widely held U.S. stocks.
In 2015, Incyte established its European headquarters in Geneva, Switzerland, and later moved this headquarters in 2021. The company expanded its Delaware headquarters, including the addition of a research and development facility, in 2022. Incyte acquired Villaris Therapeutics in 2022, and Escient Pharmaceuticals in 2024.
For 2025, the company reported $5.141 billion in revenue, $6.957 billion in assets and $1.286 billion in net income. Incyte is publicly traded on the NASDAQ under the symbol INCY. Incyte now operates out of North America, Asia, and Europe. Bill Meury became CEO in 2025. Meury replaced Hoppenot, who retired after 11 years in the position.
Pharmaceuticals
Incyte Corporation currently has seven marketed and co-marketed pharmaceutical products, including Jakafi (ruxolitinib), Pemazyre (pemigatinib), Monjuvi (tafasitamab-cxix), Opzelura (Ruxolitinib), Tabrecta (capmatinib), Olumiant (Baricitinib), and Iclusig (ponatinib).
In 2013, Novartis acquired Incyte's c-Met inhibitor capmatinib (INC280, INCB028060), which is marketed under the brand name Tabrecta.
As of 2014, the company was developing baricitinib, an oral JAK1 and JAK2 inhibitor drug for rheumatoid arthritis in partnership with Eli Lilly. It gained EU approval in February 2017. In April 2017, the US FDA issued a rejection, citing concerns about dosing and safety. In May 2018, baricitinib was approved in the United States for the treatment of rheumatoid arthritis under the brand name Olumiant.
As of 2016 epacadostat, an indoleamine 2,3-dioxygenase (IDO1) inhibitor, was in development for various cancers and was in combination trials with Merck's pembrolizumab (Keytruda) and Bristol Myers Squibb's nivolumab (Opdivo).
Acquisition history
Incyte has made a total of 3 acquisitions.
Maxia Pharmaceuticals (2003): An early acquisition in Incyte's history, the company purchased Maxia in 2003 for $42 million.
Villaris Therapeutics (2022): This acquisition was valued at approximately $1.4 billion and included an upfront payment along with milestones. It added new assets to Incyte's portfolio for treating vitiligo and other autoimmune conditions.
Escient Pharmaceuticals (2024): In May 2024, Incyte acquired this San Diego-based, clinical-stage company for $750 million. The acquisition provided Incyte with two oral drug candidates for inflammatory diseases, EP262 and EP547.
Sumber: Wikipedia (English), CC BY-SA 4.0 · Lihat di Wikipedia ↗
INCY Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$127.56
Kapitalisasi Pasar
$25.31B
P/E (TTM)
19.9
EPS (TTM)
$6.41
Pendapatan (TTM)
$5.14B
Imbal Hasil Dividen
—
ROE
27.6%
D/E Utang/Ekuitas
—
Rentang 52M
$81 – $133
INCY Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
Configure
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Pendapatan & Laba Bersih
$5.14B
2016-12-31
→
2025-12-31
EPS
$6.41
2016-12-31
→
2025-12-31
Arus Kas Bebas
—
2017-12-31
→
2022-12-31
Margin
25.0%
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
Metrik
Tren 5 Tahun
INCY
Median Rekan
P/E (TTM)
19.9
17.7
P/S (TTM)
4.9
6.8
P/B
4.9
6.4
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
Metrik
Tren 5 Tahun
INCY
Median Rekan
Operating Margin (Margin Operasi)
29.5%
—
Net Profit Margin (Margin Laba Bersih)
25.0%
20.3%
ROA
20.8%
11.4%
ROE
27.6%
16.8%
ROIC
22.7%
—
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
Metrik
Tren 5 Tahun
INCY
Median Rekan
Current Ratio (Rasio Lancar)
3.3
3.4
Quick Ratio (Rasio Cepat)
2.0
—
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
Metrik
Tren 5 Tahun
INCY
Median Rekan
Revenue YoY (Pendapatan YoY)
21.2%
—
Revenue CAGR 3Y (CAGR Pendapatan 3T)
14.8%
—
Revenue CAGR 5Y (CAGR Pendapatan 5T)
14.0%
—
EPS YoY
4173.3%
—
Net Income YoY (Laba Bersih YoY)
3845.0%
—
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
Metrik
Tren 5 Tahun
INCY
Median Rekan
INCY Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
BELI
33 analis
- Beli Kuat 8 24,2%
- Beli 9 27,3%
- Tahan 16 48,5%
- Jual 0 0,0%
- Jual Kuat 0 0,0%
Target Harga 12 Bulan
23 analis · 2026-08-18
Median
$120.00
Sekarang
$127.56
Rendah
$86.00
Tinggi
$155.00
Target median
$120.00
-5,9%
Target rata-rata
$125.17
-1,9%
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
0.33%
| Periode | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|
| 30 Juni 2026 | $3.09 | $2.14 | 0.95% |
| 31 Maret 2026 | $1.81 | $1.40 | 0.41% |
| 31 Des. 2025 | $1.80 | $1.97 | -0.17% |
| 30 Sep. 2025 | $2.26 | $1.69 | 0.57% |
| 30 Juni 2025 | $1.57 | $1.50 | 0.07% |
| 31 Maret 2025 | $1.16 | $1.04 | 0.12% |
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| INCY | $19.60B | 15.4 | 21.2% | 25.0% | 27.6% | — |
| NTRA | $32.00B | -150.7 | 35.9% | -9.0% | -14.1% | — |
| RVMD | — | — | — | — | — | — |
| BIIB | $25.84B | 20.0 | 2.2% | 13.1% | 7.2% | — |
| ALNY | $52.64B | 170.7 | 65.2% | 8.5% | 60.4% | — |
| INSM | $37.29B | -27.1 | 66.7% | -210.5% | -128.4% | — |
| UTHR | $21.27B | 17.5 | 10.6% | 41.9% | 18.7% | 87.9% |
| BBIO | $14.90B | -20.2 | 126.3% | -146.0% | 41.2% | — |
| NBIX | $14.20B | 30.4 | 21.4% | 16.7% | 16.1% | — |
| EXEL | $11.44B | 15.7 | 7.0% | 33.7% | 37.3% | — |
| BMRN | $11.43B | 33.0 | 12.9% | 10.8% | 5.8% | — |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi 17
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.14B | $4.24B | $3.70B | $3.39B | $2.99B | $2.67B | $2.16B | $1.88B | $1.54B | $1.11B | $754M | $511M | |
| Cost of Revenue | $372M | $312M | $255M | $207M | $151M | $131M | $114M | $94M | $79M | $58M | $27M | $3M | |
| R&D Expense | $2.05B | $2.61B | $1.63B | $1.59B | $1.46B | $2.22B | $1.15B | $1.20B | $1.33B | $582M | $480M | $348M | |
| SG&A Expense | $1.38B | $1.24B | $1.16B | $1.00B | $740M | $517M | $469M | $434M | $366M | $303M | $197M | $166M | |
| Operating Expenses | $3.63B | $4.18B | $3.08B | $2.82B | $2.40B | $2.93B | $1.76B | $1.75B | $1.78B | $961M | $703M | $516M | |
| Operating Income | $1.51B | $61M | $621M | $579M | $586M | $-264M | $402M | $129M | $-243M | $145M | $51M | $-5M | |
| Interest Expense | · | · | $3M | $3M | $2M | $2M | $2M | $2M | $7M | $39M | $46M | $47M | |
| Interest Income | $106M | $129M | $158M | $40M | · | · | · | · | · | · | · | · | |
| Other Non-op | $25M | $13M | $14M | $-519.0K | $11M | $23M | $52M | $32M | $17M | · | · | · | |
| Pretax Income | $1.66B | $317M | $834M | $529M | $570M | $-232M | $487M | $115M | $-312M | $107M | $8M | $-49M | |
| Income Tax | $378M | $284M | $237M | $188M | $-378M | $63M | $40M | $6M | $852.0K | $3M | $1M | $-66.0K | |
| Net Income | $1.29B | $33M | $598M | $341M | $949M | $-296M | $447M | $109M | $-313M | $104M | · | · | |
| EPS (Basic) | $6.59 | $0.16 | $2.67 | $1.53 | $4.30 | $-1.36 | $2.08 | $0.52 | $-1.53 | $0.55 | $0.04 | $-0.29 | |
| EPS (Diluted) | $6.41 | $0.15 | $2.65 | $1.52 | $4.27 | $-1.36 | $2.05 | $0.51 | $-1.53 | $0.54 | $0.03 | $-0.29 | |
| Shares (Basic) | 195,204,000 | 207,110,000 | 223,628,000 | 222,004,000 | 220,428,000 | 218,073,000 | 214,913,000 | 212,383,000 | 204,580,000 | 187,873,000 | 179,601,000 | 167,947,000 | |
| Shares (Diluted) | 200,700,000 | 210,530,000 | 225,928,000 | 223,958,000 | 222,074,000 | 218,073,000 | 217,657,000 | 215,635,000 | 204,580,000 | 194,125,000 | 187,302,000 | 167,947,000 | |
| EBITDA | $1.61B | $151M | · | $647M | $644M | $-212M | $457M | $184M | $-192M | · | · | $37M |
Neraca 27
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $3.10B | $1.69B | $3.21B | $2.95B | $2.06B | $1.51B | $1.83B | $1.16B | $900M | $652M | $521M | $452M | |
| Short-term Investments | · | · | · | · | · | · | $285M | $274M | $270M | $156M | $186M | $148M | |
| Inventory | $101M | $59M | $63M | $42M | $28M | $16M | $11M | $7M | $6M | $4M | $2M | $358.0K | |
| Prepaid Expense | $318M | $169M | $183M | $167M | $126M | $60M | $44M | $79M | $62M | $33M | $18M | $21M | |
| Current Assets | $5.02B | $3.24B | $4.65B | $4.09B | $3.12B | $2.36B | $2.48B | $1.83B | $1.50B | $994M | $842M | $680M | |
| PP&E (Net) | $731M | $763M | $752M | $739M | $724M | $560M | $378M | $320M | $260M | $168M | $86M | $82M | |
| PP&E (Gross) | $1.11B | $1.09B | $1.02B | $952M | $900M | $704M | $499M | $423M | $334M | $219M | $131M | $116M | |
| Accum. Depreciation | $375M | $328M | $270M | $213M | $176M | $144M | $122M | $103M | $75M | $52M | $45M | $35M | |
| Goodwill | $133M | $156M | $156M | $156M | $156M | $156M | $156M | $156M | $156M | $156M | · | · | |
| Intangibles | · | · | · | · | · | · | · | · | $237M | $270M | $12M | $2M | |
| Other Non-current Assets | $18M | $11M | $52M | $25M | $37M | $39M | $49M | $19M | $2M | $3M | $12M | · | |
| Total Assets | $6.96B | $5.44B | $6.78B | $5.84B | $4.93B | $3.56B | $3.43B | $2.65B | $2.30B | $1.64B | $1.01B | $796M | |
| Accounts Payable | $210M | $197M | $110M | $278M | $172M | $99M | $84M | $104M | $68M | $76M | $30M | $24M | |
| Accrued Liabilities | $1.03B | $1.21B | $936M | $701M | $534M | $378M | $286M | $229M | $199M | $127M | $87M | $62M | |
| Current Liabilities | $1.52B | $1.64B | $1.24B | $1.16B | $854M | $631M | $513M | $425M | $375M | $274M | $168M | $221M | |
| Capital Leases | $15M | $17M | $14M | $14M | $16M | $14M | $12M | · | · | · | · | · | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | $20M | |
| Other Non-current Liabilities | $165M | $168M | $149M | $99M | $70M | $58M | $40M | $22M | $20M | $13M | $48M | $55M | |
| Total Liabilities | $1.79B | $2.00B | $1.59B | $1.47B | $1.16B | $950M | $828M | $720M | $672M | $1.22B | $836M | $878M | |
| Long-term Debt | · | · | · | · | · | · | · | $19.09B | $27M | $750M | $750M | $841M | |
| Total Debt | · | · | · | · | · | · | · | · | · | · | · | $689M | |
| Common Stock | $198.0K | $193.0K | $224.0K | $223.0K | $221.0K | $219.0K | $216.0K | $213.0K | $211.0K | $189.0K | $187.0K | $171.0K | |
| Retained Earnings | $214M | $-1.07B | $160M | $-437M | $-778M | $-1.73B | $-1.43B | $-1.88B | $-1.99B | $-1.67B | $-1.78B | $-1.79B | |
| AOCI | $25M | $-13M | $13M | $15M | $-19M | $-15M | $-16M | $-10M | $-7M | $-3M | $-809.0K | $2M | |
| Stockholders' Equity | $5.17B | $3.45B | $5.19B | $4.37B | $3.77B | $2.61B | $2.60B | $1.93B | $1.63B | $419M | $171M | $-82M | |
| Liabilities + Equity | $6.96B | $5.44B | $6.78B | $5.84B | $4.93B | $3.56B | $3.43B | $2.65B | $2.30B | $1.64B | $1.01B | $796M | |
| Shares Outstanding | 198,460,009 | 193,434,305 | 224,286,862 | 222,746,719 | 221,084,433 | 219,489,329 | 216,177,830 | 213,274,660 | 211,262,906 | 188,848,752 | 186,650,249 | 170,876,619 |
Arus Kas 16
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $93M | $89M | $83M | $68M | $58M | $52M | $55M | $55M | $52M | $58M | $45M | $41M | |
| Stock-based Comp | $249M | $266M | $216M | $188M | $183M | $178M | $167M | $148M | $133M | $96M | $70M | $62M | |
| Deferred Tax | $248M | $-86M | $-159M | $57M | $-466M | $-350.0K | $-377.0K | $-459.0K | $-805.0K | · | · | · | |
| Amort. of Intangibles | $27M | $24M | $22M | $22M | $22M | $22M | $22M | $22M | $22M | $13M | · | · | |
| Other Non-cash | $-463M | $33M | · | $316M | $26M | $-58M | $43M | $24M | · | · | · | · | |
| Operating Cash Flow | $1.41B | $335M | $496M | $970M | $749M | $-125M | $711M | $336M | $-93M | $305M | $89M | $26M | |
| CapEx | · | · | · | $78M | $181M | $187M | $78M | $73M | $111M | $120M | $26M | $28M | |
| Investing Cash Flow | $-103M | $158M | $-208M | $-79M | $-208M | $-269M | $-87M | $-86M | $-350M | $-232M | $-105M | · | |
| Stock Issued | · | · | · | · | · | · | · | · | $649M | · | · | · | |
| Stock Repurchased | $0 | $2.00B | $0 | $0 | · | · | · | · | · | · | · | · | |
| Net Stock Activity | $0 | $-2.00B | · | · | · | · | · | · | $649M | · | · | · | |
| Financing Cash Flow | $101M | $-2.02B | $-20M | $-794.0K | $6M | $72M | $46M | $15M | $690M | $45M | $85M | · | |
| Net Change in Cash | $1.41B | $-1.53B | $262M | $894M | $544M | $-319M | $669M | $265M | $247M | $117M | $69M | $-19M | |
| Taxes Paid | $212M | $373M | $378M | $136M | $68M | $71M | $34M | $5M | $6M | $927.0K | · | · | |
| Free Cash Flow | · | · | · | $892M | $568M | $-312M | $633M | $263M | $-204M | · | · | $-2M | |
| Levered FCF | · | · | · | $890M | $565M | $-315M | $631M | $261M | $-211M | · | · | $-48M |
Profitabilitas 7
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 29.5% | 1.5% | · | 17.1% | 19.6% | -9.9% | 18.6% | 6.9% | -15.9% | · | · | -0.94% | |
| Net Margin | 25.0% | 0.77% | · | 10.0% | 31.8% | -11.1% | 20.7% | 5.8% | · | · | · | · | |
| Pretax Margin | 32.4% | 7.5% | · | 15.6% | 19.1% | -8.7% | 22.6% | 6.1% | -20.3% | · | · | -9.5% | |
| EBITDA Margin | 31.3% | 3.5% | · | 19.1% | 21.6% | -7.9% | 21.1% | 9.8% | -12.5% | · | · | 7.2% | |
| ROA | 20.8% | 0.53% | · | 6.3% | 22.3% | -8.5% | 14.7% | 4.4% | · | · | · | · | |
| ROE | 27.6% | 0.99% | · | 7.9% | 27.4% | -11.8% | 17.8% | 5.9% | · | · | · | · | |
| ROIC | 22.7% | 0.18% | · | 8.5% | 25.8% | -12.9% | 14.2% | 6.4% | -15.0% | · | · | -0.79% |
Likuiditas & Solvabilitas 4
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.3 | 2.0 | · | 3.5 | 3.7 | 3.7 | 4.8 | 4.3 | 4.0 | · | · | 3.2 | |
| Quick Ratio | 2.0 | 1.0 | · | 2.6 | 2.4 | 2.4 | 4.1 | 3.4 | 3.1 | · | · | 2.7 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | -8.4 | |
| Interest Coverage | · | · | · | 217.3 | 307.0 | -121.3 | 216.7 | 83.7 | -35.3 | · | · | -0.1 |
Efisiensi 2
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.7 | · | 0.6 | 0.7 | 0.8 | 0.7 | 0.8 | 0.8 | · | · | 0.7 | |
| Inventory Turnover | 4.7 | 5.1 | · | 5.9 | 6.8 | 9.4 | 12.4 | 14.0 | 15.0 | · | · | 7.9 |
Tingkat Pertumbuhan 7
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 21.2% | 14.8% | 8.9% | 13.7% | 12.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 14.8% | 12.4% | 11.5% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 14.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 4173.3% | -94.3% | 74.3% | -64.4% | · | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 61.6% | -67.2% | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 3845.0% | -94.5% | 75.4% | -64.1% | · | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 55.7% | -67.5% | · | · | · | · | · | · | · | · | · | · |
Valuasi (TTM) 10
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $5.14B | $4.24B | $3.70B | $3.39B | $2.99B | $2.67B | $2.16B | $1.88B | $1.54B | $1.11B | $754M | $511M | |
| Net Income TTM | $1.29B | $33M | $598M | $341M | $949M | $-296M | $447M | $109M | $-313M | $104M | · | · | |
| Market Cap | $19.60B | $13.36B | · | $17.89B | $16.23B | $19.09B | $18.88B | $13.56B | $20.01B | · | · | · | |
| P/E | 15.4 | 460.5 | 23.7 | 52.8 | 17.2 | -64.0 | 42.6 | 124.7 | -61.9 | 185.7 | 3615.0 | -252.1 | |
| P/S | 3.8 | 3.2 | · | 5.3 | 5.4 | 7.2 | 8.7 | 7.2 | 13.0 | · | · | · | |
| P/B | 3.8 | 3.9 | · | 4.1 | 4.3 | 7.3 | 7.3 | 7.0 | 12.3 | · | · | · | |
| P / Tangible Book | 3.9 | 4.1 | 2.8 | 4.2 | 4.5 | 7.8 | · | · | · | · | · | · | |
| P / Cash Flow | 13.9 | 39.8 | · | 18.4 | 21.7 | -153.2 | 26.6 | 40.3 | -215.2 | · | · | · | |
| P / FCF | · | · | · | 20.1 | 28.5 | -61.2 | 29.8 | 51.6 | -98.1 | · | · | · | |
| Earnings Yield | 6.5% | 0.22% | 4.2% | 1.9% | 5.8% | -1.6% | 2.4% | 0.80% | -1.6% | 0.54% | 0.03% | -0.40% |
Laporan Laba Rugi 17
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.67B | $1.27B | $1.51B | $1.37B | $1.22B | $1.05B | $1.18B | $1.14B | $1.04B | $881M | $1.01B | $919M | $955M | $809M | $927M | $823M | |
| Cost of Revenue | $105M | $105M | $121M | $99M | $79M | $73M | $88M | $86M | $77M | $61M | $70M | $60M | $68M | $57M | $59M | $55M | |
| R&D Expense | $517M | $516M | $611M | $507M | $495M | $437M | $466M | $573M | $1.14B | $429M | $444M | $376M | $401M | $407M | $501M | $384M | |
| SG&A Expense | $352M | $328M | $390M | $329M | $331M | $326M | $327M | $309M | $306M | $300M | $288M | $268M | $284M | $316M | $273M | $266M | |
| Operating Expenses | $976M | $972M | $1.17B | $922M | $685M | $848M | $877M | $992M | $1.52B | $789M | $826M | $704M | $761M | $784M | $857M | $685M | |
| Operating Income | $698M | $301M | $336M | $444M | $530M | $205M | $302M | $146M | $-478M | $92M | $187M | $215M | $194M | $25M | $70M | $138M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $430.0K | · | $623.0K | $655.0K | $469.0K | · | $641.0K | |
| Interest Income | $38M | $34M | $31M | $27M | $25M | $23M | $21M | $19M | $41M | $47M | · | · | · | · | · | · | |
| Other Non-op | $6M | $3M | $6M | $4M | $7M | $8M | $2M | $5M | $8M | $-2M | $-108M | $46M | $43M | $33M | $-14M | $12M | |
| Pretax Income | $752M | $344M | $390M | $482M | $558M | $234M | $314M | $157M | $-390M | $236M | $271M | $234M | $278M | $52M | $81M | $149M | |
| Income Tax | $166M | $40M | $91M | $58M | $153M | $76M | $113M | $50M | $55M | $67M | $70M | $63M | $74M | $30M | $52M | $36M | |
| Net Income | $586M | $303M | $299M | $424M | $405M | $158M | $201M | $106M | $-445M | $170M | $201M | $171M | $204M | $22M | $28M | $113M | |
| EPS (Basic) | $2.92 | $1.52 | $1.51 | $2.17 | $2.09 | $0.82 | $0.89 | $0.55 | $-2.04 | $0.76 | $0.90 | $0.76 | $0.91 | $0.10 | $0.12 | $0.51 | |
| EPS (Diluted) | $2.81 | $1.47 | $1.46 | $2.11 | $2.04 | $0.80 | $0.90 | $0.54 | $-2.04 | $0.75 | $0.89 | $0.76 | $0.90 | $0.10 | $0.13 | $0.50 | |
| Shares (Basic) | 200,378,000 | 199,343,000 | -388,173,000 | 195,670,000 | 193,995,000 | 193,712,000 | -428,178,000 | 192,629,000 | 218,175,000 | 224,484,000 | -446,658,000 | 224,078,000 | 223,248,000 | 222,960,000 | -443,397,000 | 222,415,000 | |
| Shares (Diluted) | 208,216,000 | 206,830,000 | -397,670,000 | 201,429,000 | 198,744,000 | 198,197,000 | -430,702,000 | 195,838,000 | 218,175,000 | 227,219,000 | -451,477,000 | 226,167,000 | 225,649,000 | 225,589,000 | -446,828,000 | 224,175,000 | |
| EBITDA | $698M | $325M | · | $444M | $530M | $228M | · | $146M | $-478M | $114M | · | $215M | $194M | $44M | · | $138M |
Neraca 22
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $3.98B | $3.46B | $3.10B | $2.46B | $1.95B | $1.94B | $1.69B | $1.30B | $987M | $3.35B | · | $3.23B | $3.13B | $2.82B | · | $2.69B | |
| Inventory | $113M | $116M | $101M | $83M | $83M | $64M | $59M | $70M | $101M | $64M | · | $57M | $36M | $41M | · | $46M | |
| Prepaid Expense | $253M | $301M | $318M | $369M | $296M | $212M | $169M | $205M | $208M | $189M | · | $172M | $167M | $194M | · | $180M | |
| Current Assets | $6.03B | $5.48B | $5.02B | $4.28B | $3.64B | $3.51B | $3.24B | $2.81B | $2.57B | $4.85B | · | $4.40B | $4.26B | $3.97B | · | $3.82B | |
| PP&E (Net) | $709M | $720M | $731M | $799M | $799M | $765M | $763M | $773M | $762M | $720M | · | $733M | $749M | $742M | · | $716M | |
| PP&E (Gross) | $1.11B | $1.11B | $1.11B | $1.16B | $1.14B | $1.11B | $1.09B | $1.09B | $1.06B | $1.00B | · | $986M | $988M | $967M | · | $918M | |
| Accum. Depreciation | $404M | $389M | $375M | $361M | $346M | $344M | $328M | $316M | $298M | $283M | · | $253M | $239M | $226M | · | $202M | |
| Goodwill | $133M | $133M | $133M | $156M | $156M | $156M | $156M | $156M | $156M | $156M | · | $156M | $156M | $156M | · | $156M | |
| Other Non-current Assets | $87M | $24M | $18M | $32M | $33M | $30M | $11M | $40M | $22M | $47M | · | $81M | $32M | $21M | · | $24M | |
| Total Assets | $7.87B | $7.34B | $6.96B | $6.33B | $5.82B | $5.75B | $5.44B | $5.01B | $4.66B | $7.14B | · | $6.39B | $6.21B | $5.80B | · | $5.51B | |
| Accounts Payable | $250M | $229M | $210M | $172M | $241M | $196M | $197M | $179M | $148M | $164M | · | $139M | $156M | $56M | · | $163M | |
| Accrued Liabilities | $870M | $1.09B | $1.03B | $948M | $857M | $1.38B | $1.21B | $1.13B | $1.03B | $1.10B | · | $821M | $811M | $825M | · | $700M | |
| Current Liabilities | $1.31B | $1.49B | $1.52B | $1.34B | $1.28B | $1.72B | $1.64B | $1.50B | $1.34B | $1.40B | · | $1.12B | $1.12B | $1.01B | · | $1.01B | |
| Capital Leases | · | · | $15M | · | · | · | $17M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $125M | $127M | $165M | $171M | $180M | $176M | $168M | $145M | $142M | $151M | · | $133M | $140M | $118M | · | $75M | |
| Total Liabilities | $1.53B | $1.72B | $1.79B | $1.68B | $1.65B | $2.08B | $2.00B | $1.84B | $1.66B | $1.74B | · | $1.46B | $1.47B | $1.34B | · | $1.28B | |
| Common Stock | $201.0K | $200.0K | $198.0K | $196.0K | $194.0K | $193.0K | $193.0K | $192.0K | $191.0K | $224.0K | · | $224.0K | $223.0K | $223.0K | · | $222.0K | |
| Retained Earnings | $1.10B | $517M | $214M | $-86M | $-510M | $-915M | $-1.07B | $-1.27B | $-1.38B | $330M | · | $-41M | $-212M | $-416M | · | $-466M | |
| AOCI | $20M | $22M | $25M | $15M | $13M | $-6M | $-13M | $16M | $-5M | $-6M | · | $23M | $27M | $21M | · | $-29M | |
| Stockholders' Equity | $6.34B | $5.62B | $5.17B | $4.65B | $4.17B | $3.67B | $3.45B | $3.17B | $3.00B | $5.39B | $5.19B | $4.93B | $4.74B | $4.46B | $4.37B | $4.23B | |
| Liabilities + Equity | $7.87B | $7.34B | $6.96B | $6.33B | $5.82B | $5.75B | $5.44B | $5.01B | $4.66B | $7.14B | · | $6.39B | $6.21B | $5.80B | · | $5.51B | |
| Shares Outstanding | 200,977,687 | 199,948,401 | 198,460,009 | 196,130,993 | 194,123,265 | 193,783,446 | 193,434,305 | 192,798,328 | 191,572,449 | 224,533,449 | · | 224,101,839 | 223,338,330 | 223,061,787 | · | 222,454,839 |
Arus Kas 10
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $26M | $24M | $24M | $24M | $23M | $22M | $23M | $23M | $22M | $22M | $22M | $21M | $20M | $19M | $18M | $17M | |
| Stock-based Comp | $67M | $64M | $62M | $62M | $65M | $61M | $72M | $78M | $57M | $60M | $60M | $48M | $55M | $53M | $53M | $45M | |
| Other Non-cash | · | $-22M | · | · | · | $25M | · | · | · | $-32M | · | · | · | $-200M | · | · | |
| Operating Cash Flow | $508M | $369M | $543M | $559M | $45M | $266M | $381M | $311M | $-576M | $219M | $148M | $148M | $307M | $-106M | $284M | $296M | |
| CapEx | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $28M | |
| Investing Cash Flow | $-52M | $-88M | $-37M | $-47M | $-19M | $1M | $-21M | $38M | $214M | $-73M | $-154M | $-17M | $-7M | $-29M | $-21M | $-28M | |
| Stock Repurchased | · | · | $0 | $0 | · | · | $0 | $103.0K | · | · | $0 | $0 | · | · | · | · | |
| Financing Cash Flow | $65M | $85M | $138M | $-13M | $-11M | $-13M | $20M | $-32M | $-2.00B | $-12M | $346.0K | $-37M | $13M | $4M | $-2M | $-14M | |
| Net Change in Cash | $521M | $363M | $643M | $500M | $13M | $254M | $384M | $317M | $-2.36B | $133M | $-14M | $96M | $310M | $-130M | $261M | $255M | |
| Taxes Paid | $15M | $-9M | $27M | $7M | $177M | $844.0K | $70M | $73M | $227M | $3M | $125M | $116M | $130M | $7M | $20M | $40M |
Profitabilitas 7
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 41.7% | 23.7% | · | 32.5% | 43.6% | 19.5% | · | 12.8% | -45.8% | 10.4% | · | 23.4% | 20.3% | 3.1% | · | 16.8% | |
| Net Margin | 35.0% | 23.8% | · | 31.1% | 33.3% | 15.0% | · | 9.4% | -42.6% | 19.2% | · | 18.6% | 21.3% | 2.7% | · | 13.7% | |
| Pretax Margin | 44.9% | 27.0% | · | 35.3% | 45.9% | 22.2% | · | 13.8% | -37.3% | 26.8% | · | 25.4% | 29.1% | 6.4% | · | 18.1% | |
| EBITDA Margin | 41.7% | 25.5% | · | 32.5% | 43.6% | 21.6% | · | 12.8% | -45.8% | 12.9% | · | 23.4% | 20.3% | 5.4% | · | 16.8% | |
| ROA | 8.6% | 4.6% | · | 7.5% | 7.7% | 2.5% | · | 1.9% | -8.2% | 2.6% | · | 2.9% | 3.5% | 0.40% | · | 2.3% | |
| ROE | 11.1% | 6.5% | · | 10.8% | 11.3% | 3.5% | · | 2.6% | -11.5% | 3.4% | · | 3.7% | 4.6% | 0.52% | · | 3.1% | |
| ROIC | 8.6% | 4.7% | · | 8.4% | 9.2% | 3.8% | · | 3.1% | -18.2% | 1.2% | · | 3.2% | 3.0% | 0.23% | · | 2.5% |
Likuiditas & Solvabilitas 3
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.6 | 3.7 | · | 3.2 | 2.8 | 2.0 | · | 1.9 | 1.9 | 3.5 | · | 3.9 | 3.8 | 3.9 | · | 3.8 | |
| Quick Ratio | 3.0 | 2.3 | · | 1.8 | 1.5 | 1.1 | · | 0.9 | 0.7 | 2.4 | · | 2.9 | 2.8 | 2.8 | · | 2.7 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 213.7 | · | 344.6 | 295.8 | 52.8 | · | 215.9 |
Efisiensi 2
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.2 | 0.2 | 0.1 | · | 0.2 | |
| Inventory Turnover | 1.1 | 1.2 | · | 1.3 | 0.9 | 1.1 | · | 1.3 | 1.1 | 1.2 | · | 1.2 | 1.5 | 1.5 | · | 1.6 |
Valuasi (TTM) 9
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $5.53B | $4.91B | · | $4.77B | $4.45B | $4.12B | · | $3.98B | $3.80B | $3.56B | · | $3.51B | $3.50B | $3.28B | · | $3.28B | |
| Net Income TTM | $1.72B | $1.29B | · | $1.09B | $225M | $-10M | · | $3M | $100M | $566M | · | $509M | $499M | $334M | · | $494M | |
| Market Cap | $22.78B | $18.82B | · | $16.63B | $13.22B | $11.73B | · | $12.74B | $11.61B | $12.79B | · | $12.95B | $13.90B | $16.12B | · | $14.82B | |
| P/E | 13.4 | 14.7 | · | 15.4 | 50.8 | 1211.0 | · | 6610.0 | 163.8 | 22.7 | · | 25.6 | 28.0 | 48.5 | · | 30.2 | |
| P/S | 4.1 | 3.8 | · | 3.5 | 3.0 | 2.9 | · | 3.2 | 3.1 | 3.6 | · | 3.7 | 4.0 | 4.9 | · | 4.5 | |
| P/B | 3.6 | 3.3 | · | 3.6 | 3.2 | 3.2 | · | 4.0 | 3.9 | 2.4 | · | 2.6 | 2.9 | 3.6 | · | 3.5 | |
| P / Tangible Book | 3.7 | 3.4 | · | 3.7 | 3.3 | 3.3 | · | 4.2 | 4.1 | 2.4 | · | 2.7 | 3.0 | 3.7 | · | 3.6 | |
| P / Cash Flow | · | 51.0 | · | · | · | 44.1 | · | · | · | 58.5 | · | · | · | -152.7 | · | · | |
| Earnings Yield | 7.4% | 6.8% | · | 6.5% | 2.0% | 0.08% | · | 0.02% | 0.61% | 4.4% | · | 3.9% | 3.6% | 2.1% | · | 3.3% |
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
Laporan Laba Rugi
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Pendapatan | $5.14B | $4.24B | $3.70B | $3.39B | $2.99B |
| Margin Operasi % | 29.5% | 1.5% | — | 17.1% | 19.6% |
| Laba Bersih | $1.29B | $33M | $598M | $341M | $949M |
| EPS Dilusian | $6.41 | $0.15 | $2.65 | $1.52 | $4.27 |
Neraca
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Rasio Lancar | 3.3 | 2.0 | — | 3.5 | 3.7 |
| Rasio Cepat | 2.0 | 1.0 | — | 2.6 | 2.4 |
Arus Kas
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Arus Kas Bebas | — | — | — | $892M | $568M |
Berita Terbaru Berita utama terbaru yang menyebutkan perusahaan ini
Sinyal Perdagangan Sinyal beli/jual terbaru dengan harga masuk dan rasio risiko/imbalan
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
📊
Pilih metrik yang penting bagi Anda — klik ➕ di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Pemilik institusional (13F) 928 pengaju · $16.2B total · Per tanggal 30 Juni 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 123 (-1 vs Kuartal sebelumnya) | 67 (-29 vs Kuartal sebelumnya) | 352 (+38 vs Kuartal sebelumnya) | 263 (-21 vs Kuartal sebelumnya) | -2.3M |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | $3.487.217.729 | 30.762.330 | 21,54% | Saham |
| Dodge & Cox | $1.355.482.475 | 11.957.326 | 8,37% | Saham |
| VANGUARD CAPITAL MANAGEMENT LLC | $1.249.713.401 | 11.024.289 | 7,72% | Saham |
| STATE STREET CORP | $1.102.124.009 | 9.722.336 | 6,81% | Saham |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $883.198.076 | 7.791.091 | 5,46% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $472.254.570 | 4.183.857 | 2,92% | Saham |
| RENAISSANCE TECHNOLOGIES LLC | $398.135.284 | 3.512.132 | 2,46% | Saham |
| WELLINGTON MANAGEMENT GROUP LLP | $384.786.803 | 3.394.379 | 2,38% | Saham |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $311.168.439 | 2.744.958 | 1,92% | Saham |
| Robeco Institutional Asset Management B.V. | $276.795.075 | 2.441.735 | 1,71% | Saham |
| TWO SIGMA INVESTMENTS, LP | $227.123.448 | 2.003.559 | 1,40% | Saham |
| DIMENSIONAL FUND ADVISORS LP | $201.199.603 | 1.774.874 | 1,24% | Saham |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $191.845.249 | 1.692.354 | 1,19% | Saham |
| FIRST TRUST ADVISORS LP | $180.015.041 | 1.587.996 | 1,11% | Saham |
| VICTORY CAPITAL MANAGEMENT INC | $167.811.569 | 1.480.342 | 1,04% | Saham |
| Caisse de depot et placement du Quebec | $155.360.220 | 1.370.503 | 0,96% | Saham |
| AustralianSuper Pty Ltd | $135.634.220 | 1.196.491 | 0,84% | Saham |
| NORGES BANK | $126.861.970 | 1.119.107 | 0,78% | Saham |
| FMR LLC | $116.316.542 | 1.026.081 | 0,72% | Saham |
| ROYAL BANK OF CANADA | $115.263.000 | 1.016.790 | 0,71% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $106.959.694 | 943.540 | 0,66% | Saham |
| ARMISTICE CAPITAL, LLC | $102.024.567 | 900.005 | 0,63% | Saham |
| PANAGORA ASSET MANAGEMENT INC | $99.970.937 | 881.889 | 0,62% | Saham |
| GOLDMAN SACHS GROUP INC | $97.568.045 | 860.692 | 0,60% | Saham |
| VANGUARD GROUP INC | $91.396.622 | 925.348 | 0,56% | Saham |
| Sound Shore Management Inc /CT/ | $85.895.479 | 757.723 | 0,53% | Saham |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $82.953.901 | 731.774 | 0,51% | Saham |
| Gotham Asset Management, LLC | $81.567.621 | 719.545 | 0,50% | Saham |
| Pictet Asset Management Holding SA | $81.315.880 | 713.354 | 0,50% | Saham |
| VIRGINIA RETIREMENT SYSTEMS ET Al | $75.887.460 | 768.325 | 0,47% | Saham |
| MACKENZIE FINANCIAL CORP | $71.967.956 | 634.862 | 0,44% | Saham |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $65.633.852 | 578.986 | 0,41% | Saham |
| Legal & General Group Plc | $63.331.398 | 558.675 | 0,39% | Saham |
| SEB Asset Management AB | $63.307.742 | 558.467 | 0,39% | Saham |
| GLENMEDE TRUST CO NA | $60.308.653 | 532.010 | 0,37% | Saham |
| Woodline Partners LP | $58.118.538 | 512.690 | 0,36% | Saham |
| MARSHALL WACE, LLP | $56.804.130 | 501.095 | 0,35% | Saham |
| BNP PARIBAS FINANCIAL MARKETS | $56.779.870 | 500.881 | 0,35% | Saham |
| WORLDQUANT MILLENNIUM ADVISORS LLC | $55.184.782 | 486.810 | 0,34% | Saham |
| BlackRock, Inc. | $54.675.002 | 482.313 | 0,34% | Saham |
| Swiss National Bank | $54.058.437 | 476.874 | 0,33% | Saham |
| Glenmede Investment Management, LP | $53.145.338 | 626.640 | 0,33% | Saham |
| Vinva Investment Management Ltd | $53.069.578 | 462.843 | 0,33% | Saham |
| CANADA PENSION PLAN INVESTMENT BOARD | $50.161.800 | 442.500 | 0,31% | Saham |
| California Public Employees Retirement System | $48.730.290 | 429.872 | 0,30% | Saham |
| RHUMBLINE ADVISERS | $48.578.406 | 428.533 | 0,30% | Saham |
| IEQ CAPITAL, LLC | $48.141.997 | 424.682 | 0,30% | Saham |
| Mitsubishi UFJ Asset Management Co., Ltd. | $46.733.567 | 412.258 | 0,29% | Saham |
| Sumitomo Mitsui Trust Group, Inc. | $44.634.140 | 393.738 | 0,28% | Saham |
| Vanguard Global Advisers, LLC | $43.080.994 | 380.037 | 0,27% | Saham |
| MORGAN STANLEY | $42.894.746 | 378.394 | 0,27% | Saham |
| Swedbank AB | $42.100.431 | 371.387 | 0,26% | Saham |
| AMERICAN CENTURY COMPANIES INC | $39.177.443 | 345.602 | 0,24% | Saham |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $38.530.157 | 339.892 | 0,24% | Saham |
| CAPITAL FUND MANAGEMENT S.A. | $38.125.008 | 336.318 | 0,24% | Saham |
| VANGUARD ASSET MANAGEMENT, Ltd | $37.984.782 | 335.081 | 0,23% | Saham |
| Grantham, Mayo, Van Otterloo & Co. LLC | $36.114.682 | 318.584 | 0,22% | Saham |
| Aware Super Pty Ltd as trustee of Aware Super | $34.779.982 | 306.810 | 0,21% | Saham |
| Arbejdsmarkedets Tillaegspension | $33.826.624 | 298.400 | 0,21% | Saham |
| BARCLAYS PLC | $32.329.252 | 285.191 | 0,20% | Saham |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $32.129.398 | 283.428 | 0,20% | Saham |
| Ensign Peak Advisors, Inc | $30.602.212 | 269.956 | 0,19% | Saham |
| Illinois Municipal Retirement Fund | $29.511.916 | 260.338 | 0,18% | Saham |
| WINTON GROUP Ltd | $28.839.691 | 254.408 | 0,18% | Saham |
| PFA Pension, Forsikringsaktieselskab | $28.624.373 | 252.509 | 0,18% | Saham |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $26.717.581 | 236.172 | 0,17% | Saham |
| TODD ASSET MANAGEMENT LLC | $26.568.750 | 234.375 | 0,16% | Saham |
| BANK OF AMERICA CORP /DE/ | $25.899.133 | 228.468 | 0,16% | Saham |
| PRINCIPAL FINANCIAL GROUP INC | $24.961.078 | 220.193 | 0,15% | Saham |
| Andra AP-fonden | $24.381.598 | 259.048 | 0,15% | Saham |
| Quantinno Capital Management LP | $24.309.704 | 214.446 | 0,15% | Saham |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | $24.037.194 | 212.043 | 0,15% | Saham |
| Baird Financial Group, Inc. | $23.690.539 | 208.985 | 0,15% | Saham |
| Eurizon Capital SGR S.p.A. | $23.250.000 | 204.785 | 0,14% | Saham |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $22.709.932 | 241.287 | 0,14% | Saham |
| Korea Investment CORP | $22.164.827 | 195.526 | 0,14% | Saham |
| KLP KAPITALFORVALTNING AS | $21.799.695 | 192.305 | 0,13% | Saham |
| Catalio Capital Management, LP | $21.722.837 | 191.627 | 0,13% | Saham |
| PRUDENTIAL FINANCIAL INC | $21.650.853 | 190.992 | 0,13% | Saham |
| ROYAL LONDON ASSET MANAGEMENT LTD | $21.575.016 | 190.323 | 0,13% | Saham |
| Fideuram Asset Management (Ireland) dac | $20.928.446 | 213.883 | 0,13% | Saham |
| ASHFORD CAPITAL MANAGEMENT INC | $20.651.585 | 182.177 | 0,13% | Saham |
| FJARDE AP-FONDEN /FOURTH SWEDISH NATIONAL PENSION FUND | $20.401.285 | 179.969 | 0,13% | Saham |
| APG Asset Management N.V. | $20.193.310 | 203.661 | 0,12% | Saham |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $19.499.734 | 172.016 | 0,12% | Saham |
| SECTOR GAMMA AS | $19.356.560 | 170.753 | 0,12% | Saham |
| MARTINGALE ASSET MANAGEMENT L P | $19.137.209 | 168.818 | 0,12% | Saham |
| CWM, LLC | $19.084.906 | 202.772 | 0,12% | Saham |
| Bridgewater Associates, LP | $19.073.160 | 168.253 | 0,12% | Saham |
| ALLIANCEBERNSTEIN L.P. | $18.937.791 | 201.209 | 0,12% | Saham |
| Candriam S.C.A. | $18.443.367 | 162.854 | 0,11% | Saham |
| Focus Partners Wealth | $18.354.947 | 161.917 | 0,11% | Saham |
| DNB Asset Management AS | $18.304.239 | 161.470 | 0,11% | Saham |
| SEI INVESTMENTS CO | $18.019.140 | 158.955 | 0,11% | Saham |
| Trails Edge Capital Partners, LP | $17.570.800 | 155.000 | 0,11% | Saham |
| Jefferies Financial Group Inc. | $17.321.295 | 152.799 | 0,11% | Saham |
| SAWGRASS ASSET MANAGEMENT LLC | $17.250.671 | 152.176 | 0,11% | Saham |
| Mitsubishi UFJ Trust & Banking Corp | $17.215.756 | 151.868 | 0,11% | Saham |
| AVIVA PLC | $16.882.025 | 148.924 | 0,10% | Saham |
| Driehaus Capital Management LLC | $16.794.397 | 148.151 | 0,10% | Saham |
Orang dalam perusahaan 61 orang dalam · 33 pejabat · 17 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| William Meury | Chief Executive Officer | 16 Juli 2026 A | 183.129 | 0 | 0 | $0 |
| Herve Hoppenot | Special Advisor to the CEO | 15 Juli 2025 F | 517.146 | 0 | 0 | $0 |
| Christiana Stamoulis | EVP & Chief Financial Officer | 15 Juli 2025 A | 125.759 | 0 | 0 | $0 |
| David W Gryska | Executive Vice President, CFO | 16 Juli 2018 F | 10.235 | 0 | 0 | $0 |
| David C Hastings | Chief Financial Officer | 5 Juni 2014 M | 8.500 | 0 | 0 | $0 |
| Pablo J Cagnoni | President, Global Head of R&D | 19 Agu 2026 S | 183.200 | 0 | 7 | $-11.304.514 |
| Lee Heeson | EVP, Head of Incyte Intl | 23 Juli 2026 A | 32.778 | 0 | 0 | $0 |
| Michael James Morrissey | EVP, Head of Tech. Operations | 23 Juli 2026 A | 81.515 | 0 | 0 | $0 |
| Richard A. Hoffman | EVP & General Counsel | 16 Juli 2026 A | 16.861 | 0 | 0 | $0 |
| David H Gardner | EVP, Chief Strategy Officer | 16 Juli 2026 A | 16.824 | 0 | 0 | $0 |
| Ramitpal K Basi | EVP, Human Resources | 16 Juli 2026 A | 11.497 | 0 | 0 | $0 |
| Mohamed Khairie Issa | EVP, Head of U.S. Commercial | 16 Juli 2026 A | 71.797 | 0 | 1 | $-125.706 |
| Thomas Tray | Principal Accounting Officer | 16 Juli 2026 A | 21.699 | 0 | 1 | $-263.900 |
| Steven H Stein | CMO & Head of Late-Stage Dev. | 16 Juli 2026 A | 30.916 | 0 | 2 | $-3.407.541 |
| Sheila A. Denton | EVP & General Counsel | 15 Agu 2025 M | 33.200 | 0 | 0 | $0 |
| Vijay K Iyengar | EVP, GMAPPS | 16 Juli 2025 S | 40.540 | 0 | 0 | $0 |
| Barry P Flannelly | EVP & General Manager US | 16 Juli 2025 S | 35.149 | 0 | 0 | $0 |
| Matteo Trotta | EVP, GM, Dermatology US | 15 Juli 2025 A | 15.016 | 0 | 0 | $0 |
| Paula J Swain | EVP, Human Resources | 15 Juli 2025 A | 106.482 | 0 | 0 | $0 |
| Jonathan Elliott Dickinson | EVP, General Manager, Europe | 12 Sep. 2024 S | 36.390 | 0 | 0 | $0 |
| Dashyant Dhanak | EVP & Chief Scientific Officer | 14 Juli 2023 A | 58.968 | 0 | 0 | $0 |
| Maria E Pasquale | EVP & General Counsel | 14 Juli 2023 A | 69.724 | 0 | 0 | $0 |
| Paul Trower | Principal Accounting Officer | 19 Jan. 2022 A | 32.268 | 0 | 0 | $0 |
| Yao Wenqing | EVP, Head of Discovery Chem | 2 Juli 2021 A | 98.575 | 0 | 0 | $0 |
| Reid M Huber | EVP, Chief Scientific Officer | 16 Juli 2018 F | 34.571 | 0 | 0 | $0 |
| Eric H. Siegel | EVP, General Counsel | 13 Sep. 2017 F | 21.053 | 0 | 0 | $0 |
| Richard S Levy | EVP, Chief Drug Dev Officer | 6 Jan. 2016 M | 16.926 | 0 | 0 | $0 |
| James M Daly | EVP, Chief Commercial Officer | 23 Juni 2015 M | 3.521 | 0 | 0 | $0 |
| Patricia S Andrews | Chief Commercial Officer | 19 Jan. 2012 A | — | 0 | 0 | $0 |
| Patricia A Schreck | EVP, General Counsel | 10 Mei 2011 M | 4.500 | 0 | 0 | $0 |
| Brian W Metcalf | Chief Drug Discovery Scientist | 11 April 2011 M | 66.504 | 0 | 0 | $0 |
| Steven M. Friedman | EVP, Biology & Preclinical Dev | 18 Mei 2010 A | 38.137 | 0 | 0 | $0 |
| John A Keller | Chief Business Officer | 8 Feb. 2008 A | — | 0 | 0 | $0 |
| Paul J Clancy | Direktur | 30 Juni 2026 A | 25.635 | 0 | 1 | $-1.423.950 |
| Edmund Harrigan | Direktur | 30 Juni 2026 A | 23.019 | 0 | 0 | $0 |
| Katherine A High | Direktur | 8 Juni 2026 A | 14.983 | 0 | 0 | $0 |
| Jacqualyn A Fouse | Direktur | 8 Juni 2026 A | 20.968 | 0 | 0 | $0 |
| Jean Jacques Bienaime | Direktur | 8 Juni 2026 A | 24.424 | 0 | 0 | $0 |
| Otis W Brawley | Direktur | 8 Juni 2026 A | 12.894 | 0 | 0 | $0 |
| Susanne Schaffert | Direktur | 12 Juni 2024 A | 5.720 | 0 | 0 | $0 |
| Wendy L Dixon | Direktur | 31 Maret 2022 A | 17.768 | 0 | 0 | $0 |
| Paul A Friedman, M.D. | Direktur | 26 Mei 2020 A | 256.813 | 0 | 0 | $0 |
| Paul A Brooke | Direktur | 31 Maret 2020 A | 221.911 | 0 | 0 | $0 |
| Barry A Ariko | Direktur | 12 Maret 2015 M | 45.834 | 0 | 0 | $0 |
| Richard U De Schutter | Direktur | 5 Maret 2015 M | 92.290 | 0 | 0 | $0 |
| Roy A Whitfield | Direktur | 17 Des. 2013 M | 666.082 | 0 | 0 | $0 |
| John F Niblack | Direktur | 20 Mei 2011 A | — | 0 | 0 | $0 |
| Fred B Craves | Direktur | 1 Juni 2005 A | 196.793 | 0 | 0 | $0 |
| INCYTE CORP | Pemilik 10% | 25 Jan. 2021 A | 3.550.000 | 0 | 0 | $0 |
| DAMIAL FOUNDATION INC | Pemilik 10% | 11 Feb. 2004 S | — | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Aktivis & pemilik 5%+ 7 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| Baker Bros. Advisors LP, Baker Bros. Advisors (GP) LLC, Julian C. Baker, Felix J. Baker, FBB2, LLC, FBB3 LLC, FBB Associates ×21 pengajuan | 11 Mei 2026 | 15,60% | Amandemen | Investasi pasif | SEC |
| Incyte Corporation ×3 pengajuan | 14 Agu 2023 | — | Pengajuan awal | Struktur modal | SEC |
| Baker Bros. Advisors, LLC, Julian C. Baker, Felix J. Baker, FBB2, LLC, FBB Associates ×2 pengajuan | 15 Juni 2012 | — | Pengajuan awal | — | SEC |
| Julian C. Baker, Felix J. Baker ×12 pengajuan | 1 Okt. 2009 | — | Pengajuan awal | — | SEC |
| Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan | 25 Feb. 2004 | — | Pengajuan awal | — | SEC |
| Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan | 29 Sep. 2003 | — | Pengajuan awal | — | SEC |
| Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan | 15 Agu 2002 | — | Pengajuan awal | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Kepemilikan ETF Dimiliki oleh 214 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| BRNY · EA Series Trust | 3,64% | 211.562 NS | 30 April 2026 | N-PORT |
| IDNA · iShares Trust | 3,62% | 71.574 SH | 20 Agu 2026 | Harian |
| PBE · Invesco Exchange-Traded Fund Trust | 2,99% | 94.349 SH | 20 Agu 2026 | Harian |
| UPGD · Invesco Exchange-Traded Fund Trust | 2,46% | 23.365 SH | 20 Agu 2026 | Harian |
| BUL · Pacer Funds Trust | 2,38% | 31.787 NS | 30 April 2026 | N-PORT |
| SAWG · ETF Series Solutions | 2,36% | 624 NS | 30 April 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 2,19% | 201.047 NS | 30 April 2026 | N-PORT |
| FGSI · First Trust Exchange-Traded Fund IV | 1,98% | 623 NS | 30 April 2026 | N-PORT |
| SMRI · EA Series Trust | 1,96% | 111.283 NS | 30 April 2026 | N-PORT |
| SPGP · Invesco Exchange-Traded Fund Trust | 1,87% | 335.552 SH | 20 Agu 2026 | Harian |
| RPG · Invesco Exchange-Traded Fund Trust | 1,87% | 286.479 SH | 20 Agu 2026 | Harian |
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 1,78% | 9.967 NS | 30 April 2026 | N-PORT |
| IBB · iShares Trust | 1,74% | 1.479.957 SH | 20 Agu 2026 | Harian |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,72% | 112.166 SH | 20 Agu 2026 | Harian |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 1,60% | 11.057 SH | 20 Agu 2026 | Harian |
| BBP · ETFis Series Trust I | 1,59% | 9.918 NS | 30 April 2026 | N-PORT |
| ABOT · Abacus FCF ETF Trust | 1,59% | 736 NS | 30 April 2026 | N-PORT |
| CALF · Pacer Funds Trust | 1,55% | 561.166 NS | 30 April 2026 | N-PORT |
| NUMG · Nushares ETF Trust | 1,44% | 53.580 NS | 30 April 2026 | N-PORT |
| AGNG · Global X Funds | 1,36% | 11.515 NS | 31 Mei 2026 | N-PORT |
| QQQJ · Invesco Exchange-Traded Fund Trust … | 1,24% | 115.625 SH | 20 Agu 2026 | Harian |
| COWG · Pacer Funds Trust | 1,21% | 275.493 NS | 30 April 2026 | N-PORT |
| FLOW · Global X Funds | 1,20% | 3.543 NS | 31 Mei 2026 | N-PORT |
| GURU · Global X Funds | 1,01% | 6.203 NS | 30 April 2026 | N-PORT |
| BIB · ProShares Trust | 0,97% | 7.359 NS | 31 Mei 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,94% | 51.287 NS | 30 April 2026 | N-PORT |
| TMFX · RBB Fund, Inc. | 0,94% | 3.113 NS | 31 Mei 2026 | N-PORT |
| OASC · Unified Series Trust | 0,91% | 7.915 NS | 31 Mei 2026 | N-PORT |
| LSVD · ADVISORS' INNER CIRCLE FUND | 0,89% | 56.482 NS | 30 April 2026 | N-PORT |
| ROE · EA Series Trust | 0,87% | 23.347 NS | 29 Mei 2026 | N-PORT |
| SPVM · Invesco Exchange-Traded Fund Trust | 0,84% | 9.113 SH | 20 Agu 2026 | Harian |
| JMID · Janus Detroit Street Trust | 0,83% | 1.595 NS | 30 April 2026 | N-PORT |
| JOET · Virtus ETF Trust II | 0,79% | 19.541 NS | 30 April 2026 | N-PORT |
| INFO · Harbor ETF Trust | 0,75% | 61.119 NS | 30 April 2026 | N-PORT |
| SDG · iShares Trust | 0,73% | 10.188 SH | 20 Agu 2026 | Harian |
| CLSE · Trust for Professional Managers | 0,71% | 45.326 NS | 31 Mei 2026 | N-PORT |
| FTC · First Trust Exchange-Traded AlphaDE… | 0,64% | 85.796 NS | 30 April 2026 | N-PORT |
| QGRO · AMERICAN CENTURY ETF TRUST | 0,64% | 146.423 NS | 31 Mei 2026 | N-PORT |
| ESMV · iShares Trust | 0,55% | 339 SH | 20 Agu 2026 | Harian |
| VBK · VANGUARD INDEX FUNDS | 0,53% | 2.249.253 SH | 19 Agu 2026 | Harian |
| EBI · RBB Fund Trust | 0,52% | 35.279 NS | 31 Mei 2026 | N-PORT |
| TECB · iShares Trust | 0,50% | 19.516 SH | 20 Agu 2026 | Harian |
| USMV · iShares Trust | 0,48% | 908.964 SH | 20 Agu 2026 | Harian |
| AFMC · First Trust Exchange-Traded Fund VI… | 0,48% | 7.994 NS | 31 Mei 2026 | N-PORT |
| VFQY · VANGUARD WELLINGTON FUND | 0,46% | 19.147 SH | 19 Agu 2026 | Harian |
| AFLG · First Trust Exchange-Traded Fund VI… | 0,45% | 29.860 NS | 31 Mei 2026 | N-PORT |
| FLCV · Federated Hermes ETF Trust | 0,44% | 4.411 NS | 31 Mei 2026 | N-PORT |
| COWZ · Pacer Funds Trust | 0,44% | 832.413 NS | 30 April 2026 | N-PORT |
| QQWZ · Pacer Funds Trust | 0,43% | 2.130 NS | 30 April 2026 | N-PORT |
| ACWV · iShares, Inc. | 0,42% | 111.137 SH | 20 Agu 2026 | Harian |